Session Chair Profile
M.D., PMWC 2014 Program Chair
Dr. Marton serves as a consultant to industry and to nonprofit, governmental, and academic institutions. In the nonprofit sector, Dr. Marton serves on the Board of Trustees of the American Association for Cancer Research Foundation, and on the Board of Directors of Cancer Commons, Rapid Science, and the Bay Area American Committee for the Weizmann Institute of Science. In the for-profit sector, he serves on the Board of Directors of TOMA Biosciences, RenovoRx, Microsonic Systems and Pathologica, is Chair of the Scientific Advisory Board of PharmaJet, is on the Advisory Boards of Gem Pharmaceuticals, Matternet, Silicom Ventures, and the PMWC. Dr. Marton received his MD from the Albert Einstein College of Medicine and his BA from Yeshiva University.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: This session focuses on community oncologists in their quest to integrate and embrace precision oncology – a very relevant topic given that 80% of oncology care in the US takes place in the community setting. We will hear from a community oncologist and a health care administrator about how they overcome struggles to solidify a process for institutional engagement while incorporating precision oncology into practice.